Journal
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Volume 18, Issue 4, Pages 1183-1187Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-08-0814
Keywords
-
Funding
- National Natural Science Foundation of China [30730080]
- National Outstanding Youth Science Foundation of China [30425001]
- China National Key Basic Research Program [2002CB512902]
- Natural Science Foundation of Jiangsu Province [BS2006005]
Ask authors/readers for more resources
microRNAs (miRNA) are a new class of non-proteincoding, small RNAs that function as tumor suppressors or oncogenes,. They participate in diverse biological pathways and function as gene regulators. Recently, we conducted a survey of common single nucleotide polymorphisms (SNP) in miRNA sequences and reported that, among four SNPs (rs2910164, rs2292832, rs11614913, and rs3746444) in pre-miRNAs, rs11614913 in miR-196a2 might affect mature miR-196a expression and target mRNA-binding activity and was significantly associated with non-small cell lung cancer survival. However, it remains largely unknown whether miRNA SNPs may alter lung cancer susceptibility. In the current study, we evaluated associations between the above four SNPs in pre-miRNAs and lung cancer susceptibility in a case-control study of 1,058 incident lung cancer patients and 1,035 cancer-free controls in a Chinese population. We found that miR-196a2 rs11614913 variant homozygote CC was associated with similar to 25% significantly increased risk of lung cancer compared with their wild-type homozygote TT and heterozygote TC (odds ratio, 1.25; 95% confidence interval, 1.01-1.54). However, no significant effects were observed on the association between the other three SNPs and lung cancer risk. These findings suggest that functional SNP rs11614913 in miR-196a2 could also contribute to lung cancer susceptibility. (Cancer Epidemiol Biorriarkers Prev 2009;18(4):1183-7)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available